Specifically, PHF6 was negatively correlated with stromal score, immune score, and ESTIMATE score in glioma (Figure 3A,E,I), lower-grade glioma (LGG) (Figure 3B,F,J), sarcoma (SARC) (Figure 3C,G,K), and lung squamous cell carcinoma (LUSC) (Figure 3D,H,L). Here, PHF6 is linked to sarcoma.